| Birth weight and risk of type 2 diabetes: a systematic review PH Whincup, SJ Kaye, CG Owen, R Huxley, DG Cook, S Anazawa, ... Jama 300 (24), 2886-2897, 2008 | 1204 | 2008 |
| Serum levels of C‐reactive protein in Crohn's disease and ulcerative colitis EA Fagan, RF Dyck, PN Maton, HJF Hodgson, VS Chadwick, A Petrie, ... European journal of clinical investigation 12 (4), 351-359, 1982 | 434 | 1982 |
| Binding of serum amyloid P-component (SAP) by amyloid fibrils. MB Pepys, RF Dyck, FC De Beer, M Skinner, AS Cohen Clinical and experimental immunology 38 (2), 284, 1979 | 349 | 1979 |
| Cyclosporin-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion Canadian-European Randomized Control Trial Group Diabetes 37 (11), 1574-1582, 1988 | 304 | 1988 |
| Epidemiology of diabetes mellitus among First Nations and non-First Nations adults R Dyck, N Osgood, TH Lin, A Gao, MR Stang Cmaj 182 (3), 249-256, 2010 | 296 | 2010 |
| Amyloid P-component is a constituent of normal human glomerular basement membrane. RF Dyck, CM Lockwood, M Kershaw, N McHugh, VC Duance, ML Baltz, ... The Journal of experimental medicine 152 (5), 1162-1174, 1980 | 254 | 1980 |
| A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district R Dyck, H Klomp, LK Tan, RW Turnell, MA Boctor Diabetes care 25 (3), 487-493, 2002 | 246 | 2002 |
| Amyloid P component is located on elastic fibre microfibrils in normal human tissue SM Breathnach, SM Melrose, B Bhogal, FC De Beer, RF Dyck, G Tennentt, ... Nature 293 (5834), 652-654, 1981 | 232 | 1981 |
| Biology of serum amyloid P component MB Pepys, ML Baltz, FC De Beer, RF Dyck, S Holford, SM Breathnach, ... Annals of the New York Academy of Sciences 389 (1), 286-298, 1982 | 182 | 1982 |
| The inter-and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes ND Osgood, RF Dyck, WK Grassmann American journal of public health 101 (1), 173-179, 2011 | 180 | 2011 |
| A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. E Cole, D Cattran, A Magil, C Greenwood, D Churchill, D Sutton, W Clark, ... American journal of kidney diseases: the official journal of the National …, 1992 | 175* | 1992 |
| A subclavian cannula for temporary vascular access for hemodialysis or plasmapheresis PR Uldall, D RF, F Woods, N Merchant, M GS, C CJ | 175 | 1979 |
| Natural course of remission in IDDM during 1st yr after diagnosis S Martin, B Pawlowski, B Greulich, AG Ziegler, T Mandrup-Poulsen, ... Diabetes Care 15 (1), 66-74, 1992 | 135 | 1992 |
| From “thrifty genotype” to “hefty fetal phenotype”: the relationship between high birthweight and diabetes in Saskatchewan Registered Indians RF Dyck, H Klomp, L Tan Canadian Journal of Public Health 92, 340-344, 2001 | 122 | 2001 |
| Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects S Martin, G Schernthaner, J Nerup, FA Gries, VA Koivisto, J Dupre, ... Diabetologia 34 (6), 429-434, 1991 | 107 | 1991 |
| Inorganic components of drinking water and microalbuminuria Y Mao, M Desmeules, D Schaubel, D Berube, R Dyck, D Brule, B Thomas Environmental research 71 (2), 135-140, 1995 | 102 | 1995 |
| Activity and barriers in girls (8-16 yr) based on grade and maturity status. LB Sherar, NC Gyurcsik, ML Humbert, RF Dyck, S Fowler-Kerry, ... Medicine and science in sports and exercise 41 (1), 87, 2009 | 99 | 2009 |
| Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis SM Breathnach, B Bhogal, RF Dyck, FC De Beer, MM Black, MB Pepys British Journal of Dermatology 105 (2), 115-124, 1981 | 93 | 1981 |
| Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and management of Diabetes in Canada: type 2 diabetes in Aboriginal Peoples SB Harris, O Bhattacharyya, R Dyck, M Naqshbandi Hayward, EL Toth Canadian Journal of Diabetes 37 (Supplement 1), S191-S196, 2013 | 92* | 2013 |
| Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes HJ Lim, X Zhang, R Dyck, N Osgood BMC medical research methodology 10, 1-10, 2010 | 90 | 2010 |
